Cosmo Pharmaceuticals N.V.
CMOPF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2,006 | $77,376 | $75,991 | -$6,418 |
| Dep. & Amort. | $6,263 | $4,993 | $7,292 | $7,350 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1,228 | $1,271 | $803 | $2,669 |
| Change in WC | -$5,339 | -$2,625 | $2,738 | $841 |
| Other Non-Cash | $754 | -$17,790 | $12,362 | $13,698 |
| Operating Cash Flow | $900 | $63,225 | $99,186 | $18,140 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2,624 | -$3,124 | -$1,428 | -$1,907 |
| Net Acquisitions | $0 | $0 | $0 | $1,000 |
| Inv. Purchases | $0 | -$157,364 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $33,910 | $0 | $0 |
| Other Inv. Act. | $44,598 | $87,195 | -$78,692 | $109,370 |
| Investing Cash Flow | $41,974 | -$39,383 | -$80,120 | $108,463 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$1,076 | $0 | $0 |
| Stock Issued | $0 | $3,377 | $0 | $0 |
| Stock Repurch. | -$7,915 | -$3,489 | -$2,442 | -$1,449 |
| Dividends Paid | -$24,512 | -$32,094 | $0 | -$4,222 |
| Other Fin. Act. | -$1,776 | -$1,574 | -$2,926 | -$178,593 |
| Financing Cash Flow | -$34,203 | -$34,856 | -$5,368 | -$184,264 |
| Forex Effect | -$2,218 | $754 | -$39 | $115 |
| Net Chg. in Cash | $50,749 | $42,156 | $2,141 | -$34,231 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $0 | $2,141 | $0 | $118,716 |
| End Cash | $50,749 | $44,296 | $2,141 | -$34,231 |
| Free Cash Flow | -$1,724 | $59,000 | $97,758 | $16,233 |